What type of study is this?

September 5, 2025Open Access

Supplementary Figure S3 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer

View Full Paper

Ask AI

Bookmark

Authors

Pharmacological inhibition of RORγt reduced tumor growth in lung cancer, indicating inflammation's role in tumor progression.

Inhibition of RORγt reduced tumor growth in experimental models, supporting its role in inflammation regulation.
RORγt inhibition did not alter cell proliferation, death, or survival markers, suggesting targeted effects.
The findings highlight the potential of targeting inflammation to control lung cancer progression.
Future studies may explore RORγt modulation for therapeutic strategies against lung cancer.

Yamada‐Hara et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark